<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d261" origId="Chloroprocaine"><sentence id="DrugDDI.d261.s0" origId="s0" text="The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension."><entity id="DrugDDI.d261.s0.e0" origId="s0.p1" charOffset="22-38" type="drug" text="local anesthetic"/><entity id="DrugDDI.d261.s0.e1" origId="s0.p3" charOffset="60-71" type="drug" text="epinephrine"/><entity id="DrugDDI.d261.s0.e2" origId="s0.p5" charOffset="75-89" type="drug" text="norepinephrine"/><entity id="DrugDDI.d261.s0.e3" origId="s0.p8" charOffset="112-140" type="drug" text="monoamine oxidase inhibitors"/><entity id="DrugDDI.d261.s0.e4" origId="s0.p9" charOffset="142-167" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d261.s0.e5" origId="s0.p11" charOffset="171-185" type="drug" text="phenothiazines"/><pair id="DrugDDI.d261.s0.p0" e1="DrugDDI.d261.s0.e0" e2="DrugDDI.d261.s0.e1" interaction="?"/><pair id="DrugDDI.d261.s0.p1" e1="DrugDDI.d261.s0.e0" e2="DrugDDI.d261.s0.e2" interaction="?"/><pair id="DrugDDI.d261.s0.p2" e1="DrugDDI.d261.s0.e0" e2="DrugDDI.d261.s0.e3" interaction="?"/><pair id="DrugDDI.d261.s0.p3" e1="DrugDDI.d261.s0.e0" e2="DrugDDI.d261.s0.e4" interaction="?"/><pair id="DrugDDI.d261.s0.p4" e1="DrugDDI.d261.s0.e0" e2="DrugDDI.d261.s0.e5" interaction="?"/><pair id="DrugDDI.d261.s0.p5" e1="DrugDDI.d261.s0.e1" e2="DrugDDI.d261.s0.e2" interaction="?"/><pair id="DrugDDI.d261.s0.p6" e1="DrugDDI.d261.s0.e1" e2="DrugDDI.d261.s0.e3" interaction="?"/><pair id="DrugDDI.d261.s0.p7" e1="DrugDDI.d261.s0.e1" e2="DrugDDI.d261.s0.e4" interaction="?"/><pair id="DrugDDI.d261.s0.p8" e1="DrugDDI.d261.s0.e1" e2="DrugDDI.d261.s0.e5" interaction="?"/><pair id="DrugDDI.d261.s0.p9" e1="DrugDDI.d261.s0.e2" e2="DrugDDI.d261.s0.e3" interaction="?"/><pair id="DrugDDI.d261.s0.p10" e1="DrugDDI.d261.s0.e2" e2="DrugDDI.d261.s0.e4" interaction="?"/><pair id="DrugDDI.d261.s0.p11" e1="DrugDDI.d261.s0.e2" e2="DrugDDI.d261.s0.e5" interaction="?"/><pair id="DrugDDI.d261.s0.p12" e1="DrugDDI.d261.s0.e3" e2="DrugDDI.d261.s0.e4" interaction="?"/><pair id="DrugDDI.d261.s0.p13" e1="DrugDDI.d261.s0.e3" e2="DrugDDI.d261.s0.e5" interaction="?"/><pair id="DrugDDI.d261.s0.p14" e1="DrugDDI.d261.s0.e4" e2="DrugDDI.d261.s0.e5" interaction="?"/></sentence><sentence id="DrugDDI.d261.s1" origId="s1" text="Concurrent use of these agents should generally be avoided."/><sentence id="DrugDDI.d261.s2" origId="s2" text="In situations when concurrent therapy is necessary, careful patient monitoring is essential."/><sentence id="DrugDDI.d261.s3" origId="s3" text="Concurrent administration of vasopressor drugs (for the treatment of hypotension related to obstetric blocks) and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents."><entity id="DrugDDI.d261.s3.e0" origId="s3.p31" charOffset="29-46" type="drug" text="vasopressor drugs"/><entity id="DrugDDI.d261.s3.e1" origId="s3.p39" charOffset="125-139" type="drug" text="oxytocic drugs"/><pair id="DrugDDI.d261.s3.p0" e1="DrugDDI.d261.s3.e0" e2="DrugDDI.d261.s3.e1" interaction="?"/></sentence><sentence id="DrugDDI.d261.s4" origId="s4" text="The para-aminobenzoic acid metabolite of chloroprocaine inhibits the action of sulfonamides."><entity id="DrugDDI.d261.s4.e0" origId="s4.p45" charOffset="4-26" type="drug" text="para-aminobenzoic acid"/><entity id="DrugDDI.d261.s4.e1" origId="s4.p46" charOffset="41-55" type="drug" text="chloroprocaine"/><entity id="DrugDDI.d261.s4.e2" origId="s4.p49" charOffset="79-91" type="drug" text="sulfonamides"/><pair id="DrugDDI.d261.s4.p0" e1="DrugDDI.d261.s4.e0" e2="DrugDDI.d261.s4.e1" interaction="?"/><pair id="DrugDDI.d261.s4.p1" e1="DrugDDI.d261.s4.e0" e2="DrugDDI.d261.s4.e2" interaction="?"/><pair id="DrugDDI.d261.s4.p2" e1="DrugDDI.d261.s4.e1" e2="DrugDDI.d261.s4.e2" interaction="?"/></sentence><sentence id="DrugDDI.d261.s5" origId="s5" text="Therefore, chloroprocaine should not be used in any condition in which a sulfonamide drug is being employed."><entity id="DrugDDI.d261.s5.e0" origId="s5.p51" charOffset="11-25" type="drug" text="chloroprocaine"/><entity id="DrugDDI.d261.s5.e1" origId="s5.p58" charOffset="73-84" type="drug" text="sulfonamide"/><pair id="DrugDDI.d261.s5.p0" e1="DrugDDI.d261.s5.e0" e2="DrugDDI.d261.s5.e1" interaction="?"/></sentence></document>